Related Experiment Video
Updated: Aug 17, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Cytokine gene-modified vaccines in the therapy of cancer
1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague.
Abstract:
Therapeutic strategies based on the insertion of cytokine genes into the genome of tumour cells, followed by vaccination with the resulting genetically modified, cytokine-producing cells, represent a new potential prospect for treatment of cancer patients. In this review, the concept of cytokine gene-modified cancer vaccines is discussed; the discussion is focused on the rationale, characterization, progress in the development, preclinical testing, and first clinical trials. An effort is made to analyse and integrate the results obtained in different experimental model systems in order to determine the needed approaches and directions for further research.
Insights
Genetically modified cancer vaccines, engineered to produce cytokines, offer a promising new cancer treatment. This review covers their development, preclinical testing, and early clinical trials for cancer therapy.
Area of Science:
- Immunology
- Oncology
- Gene Therapy
Background:
- Cancer immunotherapy is evolving with novel strategies.
- Cytokine gene modification of tumor cells presents a new therapeutic avenue.
Purpose of the Study:
- To review the concept of cytokine gene-modified cancer vaccines.
- To analyze their rationale, development, preclinical testing, and clinical trials.
- To identify future research directions.
Main Methods:
- Review of existing literature on cytokine gene-modified cancer vaccines.
- Analysis of preclinical data from various experimental models.
- Evaluation of early-phase clinical trial outcomes.
Main Results:
- Cytokine gene-modified cancer vaccines demonstrate therapeutic potential.
- Preclinical studies show promising anti-tumor immune responses.
- Early clinical trials are exploring safety and efficacy in cancer patients.
Conclusions:
- Cytokine gene-modified cancer vaccines represent a promising frontier in cancer treatment.
- Further research is needed to optimize approaches and integrate findings across models.
- This strategy holds potential for improving outcomes in cancer patients.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

